doi: 10.1126/science.abb8923. Epub 2020 May 8.
Rapid COVID-19 vaccine development
Affiliations
- PMID:32385100
- DOI: 10.1126/science.abb8923
Item in Clipboard
Rapid COVID-19 vaccine development
Barney S Graham. Science..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.Graepel KW, Kochhar S, Clayton EW, Edwards KE.Graepel KW, et al.J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234.J Infect Dis. 2020.PMID:32365191Free PMC article.No abstract available.
- What the immune response to the coronavirus says about the prospects for a vaccine.Ledford H.Ledford H.Nature. 2020 Sep;585(7823):20-21. doi: 10.1038/d41586-020-02400-7.Nature. 2020.PMID:32811981No abstract available.
- Coronavirus vaccines leap through safety trials - but which will work is anybody's guess.Callaway E.Callaway E.Nature. 2020 Jul;583(7818):669-670. doi: 10.1038/d41586-020-02174-y.Nature. 2020.PMID:32710003No abstract available.
- Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.Simon HU, Karaulov AV, Bachmann MF.Simon HU, et al.Int Arch Allergy Immunol. 2020;181(8):624-628. doi: 10.1159/000509368. Epub 2020 Jun 16.Int Arch Allergy Immunol. 2020.PMID:32544911Free PMC article.Review.
- Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP.Lambert PH, et al.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.Vaccine. 2020.PMID:32507409Free PMC article.
Cited by
- Effectiveness of the Inactivated SARS-CoV-2 (Vero Cell) Vaccine in Peruvian Health Workers.Solis-Castro ME, Jaramillo-Corrales A, Gonzalez Seminario RV, Janampa Grados N, Mamani Pilco IE, Vargas Quispe KE, La Torre Rosillo LY, Vásquez Dominguez MN, Enriquez Cusi DT, Minaya P, Pardo Ruiz KJ, Díaz-Vélez C, Pachas VA, Alberca RW, Pachas PE.Solis-Castro ME, et al.Life (Basel). 2022 Aug 26;12(9):1318. doi: 10.3390/life12091318.Life (Basel). 2022.PMID:36143355Free PMC article.
- Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.Chiuppesi F, Salazar MD, Contreras H, Nguyen V, Martinez J, Park S, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt N, Kang T, Wu X, Rogers T, Manuel E, Shostak Y, Diamond D, Wussow F.Chiuppesi F, et al.Res Sq [Preprint]. 2020 Jul 17:rs.3.rs-40198. doi: 10.21203/rs.3.rs-40198/v1.Res Sq. 2020.Update in:Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1.PMID:32702732Free PMC article.Updated.Preprint.
- Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.Graupensperger S, Abdallah DA, Lee CM.Graupensperger S, et al.Vaccine. 2021 Apr 8;39(15):2060-2067. doi: 10.1016/j.vaccine.2021.03.018. Epub 2021 Mar 17.Vaccine. 2021.PMID:33741191Free PMC article.
- Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.Conzelmann C, Müller JA, Perkhofer L, Sparrer KM, Zelikin AN, Münch J, Kleger A.Conzelmann C, et al.Clin Med (Lond). 2020 Nov;20(6):e218-e221. doi: 10.7861/clinmed.2020-0351. Epub 2020 Aug 30.Clin Med (Lond). 2020.PMID:32863274Free PMC article.
- Leveraging the advances in HIV for COVID-19.McMahon JH, Hoy JF, Kamarulzaman A, Bekker LG, Beyrer C, Lewin SR.McMahon JH, et al.Lancet. 2020 Oct 3;396(10256):943-944. doi: 10.1016/S0140-6736(20)32012-2.Lancet. 2020.PMID:33010825Free PMC article.No abstract available.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources